To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic

Patient Satisfaction Clinical Trial

— Coronavirus19  

Official title:

To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04412239
• Other study ID #: NO, F6-2017/NTP-ADMIN
• Status: Recruiting
• Phase: N/A
• Start date: April 20, 2020
• Est. completion date: December 20, 2020

Study information

• Verified date: November 2020
• Source: Health Science Center of Xi'an Jiaotong University
• Contact: Farman Ul Khan, Master
• Phone: 003319443131
• Email: farmankhan[@]bs.qau.edu.pk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The COVID-19 pandemic might be an opportunity to review and refine our practices in anti TB treatment. For the follow-up of selected patients, telephone consultations may be efficient and cost-effective. The aim of the study is to assess the efficiency and the satisfaction with telephone consultation for the pharmacist and the TB patient. The study was conducted in tertiary care hospital TB control centres patients.

Description:

Tuberculosis (TB) is the world's biggest killer among infectious diseases, claiming more than 4000 lives each day. The unprecedented coronavirus pandemic seriously impacts people with pre-existing health conditions. People who have TB are usually more vulnerable to other infections, including the novel coronavirus, due to pre-existing lung damage. They are at a higher risk of developing complications from COVID-19. Certain populations are at greater risk of TB, because of where they live, where they work or because of other socio-economic factors which result in them experiencing barriers to accessing health services.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: December 20, 2020
• Est. primary completion date: December 20, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

New, smear-positive drug-susceptible TB who have been on treatment for less than two weeks Access to a mobile phone (self-reported) Exclusion Criteria: Patients who do not have regular access to a mobile phone Patients who have previously received TB treatment Patients who have another member in their household who is already a part of the study

Related Conditions & MeSH terms

• Patient Satisfaction
• TB - Tuberculosis
• Tuberculosis

Intervention

Behavioral:
• Patient-centred advice on Telephone Consultation in TB Patients:
The primary aim was to assess the efficiency and the satisfaction of the telephone consultation. The COVID-19 pandemic might be an opportunity to review and refine our practices in TB care. For the follow-up of selected patients, telephone consultations may be efficient and cost effective.

Locations

Country	Name	City	State
Pakistan	Dhq Bannu Kpk	Bannu	KPK
Pakistan	District Bannu TB Control Center	Bannu	KPK

Sponsors (3)

Lead Sponsor	Collaborator
Health Science Center of Xi'an Jiaotong University	District Headquarter Hospital Bannu Pakistan, Pakistan Institute of Medical Sciences Islamabad Pakistan

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Efficiency of the telephone consultation,	To improve patient centered care/patient prescription refill	2 Months
Primary	Patient satisfaction	Patient satisfaction Patient satisfaction resulting from pharmacist-led pharmaceutical care will be assessed Patient satisfaction feedback (PSF)	2 Month
Secondary	Adherence Rate		2 Months